We are a global life sciences advisory that delivers timely insights to enhance your critical business decisions.
inThought Research empowers biopharma leaders with comprehensive strategic insights. We combine Wall Street financial acumen and swiftness, scientific expertise, and advanced AI analytics to navigate the complex landscape of drug development.
Our multidisciplinary approach integrates clinical data, market analytics, and stakeholder perspectives. Through inThought Labs, we combine cutting-edge technology with the work of our subject matter experts to transform complex data into actionable intelligence.
Indication expansion: Primary research with top experts combines with financial modeling to quantify opportunity areas for an asset
Market access optimization: Develops strategies to overcome pricing and reimbursement hurdles, maximizing product reach
Competitive positioning: Crafts differentiation strategies to outmaneuver rivals and capture market share Awesome ImageLearn
Partnership identification : Uncovers and evaluates potential collaborators, licensees, or acquisition targets to drive growth
Strategic fit assessment: Analyzes how potential deals align with company goals and capabilities to guide decision-making
Deal valuation: Provides robust financial modeling and asset valuation to ensure optimal deal terms and ROI Awesome ImageLearn
Early signal detection: Identifies emerging threats and opportunities in the competitive landscape before they become widely known
Blind spot illumination: Uncovers hidden competitive dynamics and non-obvious players that may impact the business
Competitive insight synthesis: Analyzes and contextualizes conference data to provide actionable insights and trend analysis to inform proactive decision-making
Medical Affairs
Targeted intelligence gathering: Identifies and prioritizes key sessions and presentations to maximize relevant data collection at congresses
Rapid dissemination strategies: Develops efficient methods to quickly share critical conference findings with internal stakeholders, enabling faster decision-making
KOL engagement optimization: Develops strategies to build and maintain meaningful relationships with key opinion leaders, enhancing scientific credibility
Bespoke Reports: Provides comprehensive due diligence to identify potential pitfalls and assess investment viability
ROI maximization: Offers market sizing and growth projections to pinpoint high-value opportunities
Portfolio diversification: Delivers insights on emerging trends and technologies to guide strategic investment allocation
inThought Research empowers biopharma leaders with comprehensive strategic insights. We combine Wall Street financial acumen and swiftness, scientific expertise, and advanced AI analytics to navigate the complex landscape of drug development.
© 2024 inThought Research. All Rights Reserved.
Commercial Teams
Indication expansion: Primary research with top experts combines with financial modeling to quantify opportunity areas for an asset
Market access optimization: Develops strategies to overcome pricing and reimbursement hurdles, maximizing product reach
Competitive positioning: Crafts differentiation strategies to outmaneuver rivals and capture market share Awesome ImageLearn
inThought Research empowers commercial teams with strategic insights and market intelligence to optimize product positioning, launch strategies, and revenue potential. We combine financial analysis with scientific expertise to guide pricing decisions, identify key market opportunities, and forecast sales trajectories.
Business Development
Partnership identification : Uncovers and evaluates potential collaborators, licensees, or acquisition targets to drive growth
Strategic fit assessment: Analyzes how potential deals align with company goals and capabilities to guide decision-making
Deal valuation: Provides robust financial modeling and asset valuation to ensure optimal deal terms and ROI Awesome ImageLearn
We support business development professionals in identifying and evaluating strategic opportunities. Our team provides comprehensive asset valuations, market assessments, and competitive analyses to inform licensing decisions, mergers and acquisitions, and portfolio management strategies.
Competitive Intelligence
Early signal detection: Identifies emerging threats and opportunities in the competitive landscape before they become widely known
Blind spot illumination: Uncovers hidden competitive dynamics and non-obvious players that may impact the business
Competitive insight synthesis: Analyzes and contextualizes conference data to provide actionable insights and trend analysis to inform proactive decision-making
We enhance competitive intelligence efforts by providing timely, actionable insights on competitor strategies, market dynamics, and emerging threats. Our AI-powered tools and expert analysis help teams anticipate market shifts, track competitor activities, and identify strategic advantages.
Medical Affairs
Targeted intelligence gathering: Identifies and prioritizes key sessions and presentations to maximize relevant data collection at congresses
Rapid dissemination strategies: Develops efficient methods to quickly share critical conference findings with internal stakeholders, enabling faster decision-making
KOL engagement optimization: Develops strategies to build and maintain meaningful relationships with key opinion leaders, enhancing scientific credibility
inThought Research assists medical affairs teams in developing evidence-based strategies for scientific communication and stakeholder engagement. We help optimize clinical trial designs, analyze real-world evidence, and identify key opinion leaders, ensuring that medical strategies align with both scientific advancements and market needs.
Investors
Bespoke Reports: Provides comprehensive due diligence to identify potential pitfalls and assess investment viability
ROI maximization: Offers market sizing and growth projections to pinpoint high-value opportunities
Portfolio diversification: Delivers insights on emerging trends and technologies to guide strategic investment allocation
As the president of inThought Labs, Chris is focused on constantly improving inVision, the leading competitive and market intelligence platform for the biopharmaceutical industry, to better meet the changing needs of clients.
With 20 years of experience in roles being a consumer of market and competitive information, Chris understands the needs and priorities of clients. Chris was a senior principal and co-founder of inThought, a life science consulting, market research, and analytics firm. Collaborating with Ben Weintraub, Chris also co-founded BiotechTracker, an online tool for investors and precursor to inVision. Previous to inThought, he was a healthcare analyst and co-portfolio manager at two investment firms. Chris served in health care policy roles at the White House Office of Management and Budget. These roles included Medicare Desk Officer at the Office of Information and Regulatory Affairs, where he was responsible for providing recommendations to senior White House policy officials on healthcare policies and regulations.
Chris has a Master in Business Administration from Harvard Business School, a Master in Engineering from Villanova University, and a Bachelor of Science in Engineering from Cornell University. Prior to attending Harvard Business School, Chris served on two U.S. Navy nuclear submarines and at the Pentagon.
